DOI:
10.1055/s-00034924
Nuklearmedizin - NuclearMedicine
LinksClose Window
References
Ratain MJ, Eisen T, Stadler MW. et al.
Phase II Placebo-Controlled Randomized Discontinuation Trial of Sorafenib in Patients With Metastatic Renal Cell Carcinoma.
J Clin Oncol 2006;
24: 2505-2512.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.